Re: "Inhibition of medullary thyroid carcinoma (MTC) cell proliferation and RET phosphorylation by tyrosine kinase inhibitors"

Surgery. 2004 Feb;135(2):240-1; author reply 241.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Benzamides
  • Carcinoma, Medullary / drug therapy*
  • Carcinoma, Medullary / pathology
  • Cell Division
  • Enzyme Inhibitors / therapeutic use*
  • Humans
  • Imatinib Mesylate
  • Oncogene Proteins / metabolism*
  • Phosphorylation
  • Piperazines / therapeutic use*
  • Protein-Tyrosine Kinases / antagonists & inhibitors
  • Protein-Tyrosine Kinases / metabolism
  • Proto-Oncogene Proteins c-ret
  • Pyrimidines / therapeutic use*
  • Receptor Protein-Tyrosine Kinases / metabolism*
  • Thyroid Neoplasms / drug therapy*
  • Thyroid Neoplasms / pathology

Substances

  • Benzamides
  • Enzyme Inhibitors
  • Oncogene Proteins
  • Piperazines
  • Pyrimidines
  • Imatinib Mesylate
  • Protein-Tyrosine Kinases
  • Proto-Oncogene Proteins c-ret
  • RET protein, human
  • Receptor Protein-Tyrosine Kinases